Sutro Biopharma (STRO) Cash from Operations Growth (1y) (2018 - 2025)
Sutro Biopharma (STRO) Cash from Operations Growth (1y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.87% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -28.96% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 75.58% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -119.28% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 100.14% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 151.70% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 56.79% |
| 10 | Sutro Biopharma | 339.58 Mn | 175.24 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 63.15% |
| Sep 30, 2025 | 40.81% |
| Jun 30, 2025 | -573.02% |
| Mar 31, 2025 | -4.85% |
| Dec 31, 2024 | -609.79% |
| Sep 30, 2024 | -92.57% |
| Jun 30, 2024 | 130.31% |
| Mar 31, 2024 | -6.15% |
| Dec 31, 2023 | 158.97% |
| Sep 30, 2023 | -150.87% |
| Jun 30, 2023 | -879.13% |
| Mar 31, 2023 | -73.00% |
| Dec 31, 2022 | -10.58% |
| Sep 30, 2022 | 369.83% |
| Jun 30, 2022 | 39.46% |
| Mar 31, 2022 | -15.86% |
| Dec 31, 2021 | -14.31% |
| Sep 30, 2021 | -37.97% |
| Jun 30, 2021 | 57.90% |
| Mar 31, 2021 | -62.43% |